Various Aspects of the Relationship Between Vitiligo and the Covid-19 Pandemic or Sars-Cov-2 Vaccines: Clinical Pearls for Dermatologists Publisher Pubmed



Aryanian Z^{1, 2} ; Balighi K^{1, 3} ; Hatami P¹ ; Goodarzi A^{4, 5} ; Janbakhsh A⁶ ; Afshar ZM⁶
Source: Journal of Cosmetic Dermatology Published:2023

Abstract

Background: Coronavirus disease 2019 (COVID-19) has given rise to several new onset or exacerbated dermatologic disorders including vitiligo. Aim and Method: Here, we present different aspects of relationship between SARS-CoV-2 infection or its associated vaccines and vitiligo and aim to provide solutions to overcome the potential challenges. Results and Conclusion: In brief, as the benefits overweigh the risks and since vaccine-triggered de novo or flares of vitiligo are uncommon and benign, these patients are recommended to get SARS-CoV-2 vaccines. Moreover, in individuals with previously recognized vitiligo, who are at risk of developing SARS-CoV-2 infection or those who are currently infected, special dermatologic consultation is needed in order to balance the immunosuppressive agents in their therapeutic regimen to prevent COVID-related morbidity and mortality. © 2022 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.